Pharmaceutical

Pfizer’s new Viagra ads take a new approach to selling ED drug

viagra Pfizers new Viagra ads take a new approach to selling ED drugPfizer, makers of the erectile dysfunction pill Viagra, at risk of losing market share from stiff competition, are taking a new approach to pushing the little blue pill. The company’s new advertising campaign uses a beautiful, mid-aged blond woman in a blue dress who addresses viewers by looking directly in the camera and saying, “So guys, it’s just you and your honey. The setting is perfect. But then erectile dysfunction happens again.”

The woman assures viewers that that many men lose or have difficulty getting an erection. Yes, she uses the word erection. For the first time, an erectile dysfunction drug address the problem head-on.

The ad encourages men to talk with their doctors. But it also seems to suggest that women are more upset about ED than their partners are aware. And perhaps the ads may encourage more women to persuade their partners to talk with their doctors.

Marketing experts say it is a clever strategy to increase sales of the drug, especially in light of growing competition in the ED market.

Viagra also has new warnings to contend with. Recent studies show that men who used Viagra were twice as likely to develop melanoma compared to men who never used the drug. Even men who had used Viagra at one time but discontinued use continued to have the same risk.

What is the connection? Viagra, which contains the drug ingredient sildenafil, is in a class of medications known as PDE5A inhibitors. Other drugs in this class include the ED medications Cialis, also known as tadalafil, and Levitra, also known as vardenafil. PDE5a inhibitors affect the same genetic pathway that allows skin cancer to be more aggressive.

Melanoma is the deadliest form of skin cancer, accounting for nearly 80 percent of all skin cancer-related deaths. Viagra did not appear to increase the risk of less dangerous skin cancers.

Sources:
Tech Times
Righting Injustice